Bilcare Limited FY26 Financials

Bilcare Limited reported a standalone net profit of ₹0.99 crore for the year ended March 31, 2026, a decline from ₹3.99 crore in the previous year. The company’s standalone total income also decreased to ₹26.38 crore from ₹32.97 crore.

On a consolidated basis, Bilcare reported a net loss of ₹17.29 crore for FY26, an improvement over the ₹28.13 crore net loss recorded in FY25. Consolidated total income for the year was ₹763.54 crore, down from ₹806.51 crore in the prior year.

Reader Takeaway: Mixed results with narrowing consolidated loss but persistent standalone profit decline and going concern uncertainty.

What just happened

Bilcare Limited announced its financial results for the year ended March 31, 2026. The company posted a standalone net profit of ₹0.99 crore and a consolidated net loss of ₹17.29 crore. A significant point raised by the auditors is a material uncertainty regarding the company's ability to continue as a going concern.

Why this matters

The auditor's remark on going concern uncertainty is a critical factor for investors, indicating potential financial instability. While the consolidated loss has narrowed, suggesting some operational improvements, the overall financial health remains under scrutiny. Corporate actions like preference share redemption and warrant conversion in its subsidiary, Caprihans India Limited, also impact the group's structure.

The backstory

Bilcare Limited operates in packaging solutions. The company has faced scrutiny, including an investigation by the Serious Fraud Investigation Office (SFIO), which remains sub-judice. It also has a contingent liability related to a CSIR loan and provides a significant corporate guarantee for its subsidiary, Caprihans India Limited.

What changes now

Investors need to closely monitor management's strategic plans, particularly concerning the GCS business, which is cited as key for future prospects. The company has undertaken corporate actions involving its subsidiary, Caprihans India Limited, including the redemption of preference shares and conversion of warrants, increasing its stake to 62.04%.

Risks to watch

Key risks include the ongoing SFIO investigation, the disputed penal interest on the CSIR loan (₹17.72 crore), and the substantial corporate guarantee of ₹666.96 crore for Caprihans India Limited. The company's ability to manage these liabilities and leverage future business prospects is crucial.

Peer comparison

Bilcare operates in the packaging solutions sector. While specific peer performance data for FY26 is not provided in the filing, companies in this segment often face challenges related to raw material costs, competition, and regulatory compliance. Bilcare's specific issues like the SFIO probe and going concern remarks differentiate its risk profile.

Context metrics (time-bound)

• Standalone Net Profit (FY26): ₹0.99 crore (vs. ₹3.99 crore in FY25)
• Consolidated Net Loss (FY26): ₹17.29 crore (vs. ₹28.13 crore in FY25)
• Consolidated Total Income (FY26): ₹763.54 crore (vs. ₹806.51 crore in FY25)
• Preference Share Redemption (Caprihans India): ₹15.60 crore in May 2026
• Caprihans India Corporate Guarantee: ₹666.96 crore
• Contingent Liability (CSIR Loan): ₹17.72 crore

What to track next

Investors should follow updates on the SFIO investigation, the outcome of the CSIR loan dispute in the Delhi High Court, and the operational performance of Caprihans India Limited. Management's strategy for the GCS business and any further corporate actions will also be important to monitor.